City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugsBusinessOct 9 at 6:44 AM – Oct 9 at 8:31 AM3 outletsBloombergFidelity-Backed City Therapeutics Seeks $184.7 Million in US IPO Oct 9 at 7:15 AMQuartzCity Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs Oct 9 at 8:31 AMBusiness PostFidelity-backed drug developer seeks $184.7 million in US IPO Oct 9 at 6:44 AM